Literature DB >> 17184392

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.

Walter Dowdle1, Harrie van der Avoort, Esther de Gourville, Francis Delpeyroux, Jagadish Desphande, Tapani Hovi, Javier Martin, Mark Pallansch, Olen Kew, Chris Wolff.   

Abstract

The goal of the World Health Organization is to stop routine use of oral poliovirus vaccine shortly after interruption of wild poliovirus transmission. A key component of this goal is to minimize the risk of reintroduction by destruction of polioviruses except in an absolute minimum number of facilities that serve essential functions and implement effective containment. Effective containment begins with a complete facility risk assessment. This article focuses on characterizing the risks of exposure to polioviruses from the essential vaccine production, quality control, and international reference and research facilities that remain. We consider the potential exposure pathways that might lead to a poliovirus reintroduction, including para-occupational exposures and releases to the environment, and review the literature to provide available estimates and a qualitative assessment of containment risks. Minimizing the risk of poliovirus transmission from a poliovirus facility to increasingly susceptible communities is a crucial and ongoing effort requiring understanding and actively managing the potential exposure pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184392     DOI: 10.1111/j.1539-6924.2006.00844.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  21 in total

1.  The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  Medscape J Med       Date:  2008-08-13

2.  Modeling poliovirus risks and the legacy of polio eradication.

Authors:  Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-28       Impact factor: 4.000

Review 3.  Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Konstantin M Chumakov; Neal A Halsey; Tapani Hovi; Philip D Minor; John F Modlin; Peter A Patriarca; Roland W Sutter; Peter F Wright; Steven G F Wassilak; Stephen L Cochi; Jong-Hoon Kim; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-28       Impact factor: 4.000

4.  Field Performance of Two Methods for Detection of Poliovirus in Wastewater Samples, Mexico 2016-2017.

Authors:  Concepción F Estívariz; Elda E Pérez-Sánchez; Anita Bahena; Cara C Burns; Howard E Gary; Herlinda García-Lozano; Gloria Rey-Benito; Silvia Peñaranda; Katy V Castillo-Montufar; Raúl S Nava-Acosta; John Scott Meschke; M Steven Oberste; Irma Lopez-Martínez; José A Díaz-Quiñonez
Journal:  Food Environ Virol       Date:  2019-09-30       Impact factor: 2.778

Review 5.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

6.  Poliovirus containment risks and their management.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowsa; Kimberly M Thompson
Journal:  Future Virol       Date:  2018-08-10       Impact factor: 1.831

Review 7.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 8.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

Review 9.  Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.

Authors:  Thomas R Hird; Nicholas C Grassly
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

10.  Estimating the extent of vaccine-derived poliovirus infection.

Authors:  Alison Wringe; Paul E M Fine; Roland W Sutter; Olen M Kew
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.